COVend Overview
- Website
- covend-project.eu
- Industry
- Research
- Employees
- 4
About COVend
The aim of the COVend project is to deliver a new effective therapy against endothelial damage in ARDS for the clinical management of COVID-19 and other diseases. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them. All posts reflect the views of COVend only
COVend Contact Details
- People in AeroLeads
- 4
COVend Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Resellit Undefined | San Diego, California, United States |
View
|
|
| Priv.-Doz. Dr. Med. Habil. Jan Kloka | Anesthesiologist - Clinical Data |
View
|
|
| Conor Claxton | Chief Executive Officer at Conpatian Dac | Belfast Metropolitan Area, United Kingdom |
View
|
| Benjamin Friedrichson | Anesthesiologist - Researcher |
View
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Compare Similar Companies to COVend
Systems Biology Ireland
Biotechnology Research
mAbsolve
Biotechnology Research
VAAM
Biotechnology Research
EDiHTA
Research Services
pluriSelect Life Science
Biotechnology
Data Science Group Frankfurt
Higher Education
Precision Oncology Ireland
Research Services
AVITHRAPID
Biotechnology Research
ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies
Public Health
ENVISION
Research Services